An important factor in the variation in the phenotype of SMA patients is the variation in SMN2 copy number between individuals, which is partly responsible for the observed differences in disease severity between affected individuals (D'Amico et al. 2011; Feldkötter et al. 2002). Here, SMN2 is linked to proximal spinal muscular atrophy.